Healthcare -
Biotechnology - NASDAQ - US
$ 10.12
-11.5 %
$ 467 M
Market Cap
-3.27
P/E
URGN - REVENUE
Revenue URGN - UroGen Pharma Ltd.
90.4 M
LAST VALUE
18.52%
2 YEAR CAGR
449.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR